Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases.

Those who received IT in addition to WBRT and SRS experienced longer survival compared to RT modalities alone, while those receiving concurrent SRS and IT trended toward improved survival versus nonconcurrent therapy.